New Study Clarifies Pregnancy Risks Associated with GLP-1 Weight Loss Medications
A major, large-scale study involving more than 750,000 pregnancies has provided significant new insights into the potential risks of using popular GLP-1 receptor agonist medications, such as Ozempic and Wegovy,…